SC Pharmaceuticals Stock Analysis

SCPH -  USA Stock  

USD 6.02  0.16  2.73%

SC Pharmaceuticals price drop over the last few months created some momentum for stockholders as it was traded today as low as 5.82 and as high as 6.11 per share. The company directors and management were not very successful in positioning the entity resources to exploit market volatility in June. However, diversifying your holdings with SC Pharmaceuticals or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.04. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the SC Pharmaceuticals partners.
Additionally, take a look at World Market Map.

Search Stock Analysis 

The SC Pharmaceuticals stock analysis report makes it easy to digest most publicly released information about SC Pharmaceuticals and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. SC Pharmaceuticals Stock analysis module also helps to analyze the SC Pharmaceuticals price relationship with some important fundamental indicators such as market cap and management efficiency.

SC Pharmaceuticals Stock Analysis Notes

About 66.0% of the company shares are owned by institutional investors. The book value of SC Pharmaceuticals was at this time reported as 3.01. The company recorded a loss per share of 1.31. SC Pharmaceuticals had not issued any dividends in recent years. scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. SC Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people. To find out more about SC Pharmaceuticals contact John Tucker at 617 517 0730 or learn more at

SC Pharmaceuticals Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. SC Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding SC Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
SC Pharmaceuticals generates negative expected return over the last 90 days
SC Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (32.21 M).
SC Pharmaceuticals currently holds about 105.09 M in cash with (27.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.84.
Roughly 66.0% of the company shares are owned by institutional investors
Latest headline from scPharmaceuticals Inc gains 5.98 percent for July 20 -

SC Pharmaceuticals Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as SC Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SC Pharmaceuticals backward and forwards among themselves. SC Pharmaceuticals' institutional investor refers to the entity that pools money to purchase SC Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Orbimed Advisors LlcCommon Shares4.8 M31.9 M
5am Venture Management LlcCommon Shares3.8 M25.5 M
Ra Capital Management LpCommon Shares2.7 M18.2 M
Ikarian Capital LlcCommon Shares1.3 M8.7 M
Aigh Capital Management LlcCommon Shares855.1 K5.7 M
Goldman Sachs Group IncCommon Shares648.8 K4.3 M
Vanguard Group IncCommon Shares643.5 K4.3 M
Note, although SC Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

SC Pharmaceuticals Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 164.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SC Pharmaceuticals's market, we take the total number of its shares issued and multiply it by SC Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (20.08) % which means that it has lost $20.08 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (48.24) %, meaning that it created substantial loss on money invested by shareholders. SC Pharmaceuticals management efficiency ratios could be used to measure how well sc pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 24th of July, SC Pharmaceuticals owns the standard deviation of 4.03, and Market Risk Adjusted Performance of (0.031654). In connection with fundamental indicators, the technical analysis model makes it possible for you to check timely technical drivers of SC Pharmaceuticals, as well as the relationship between them. Strictly speaking, you can use this information to find out if the entity will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for SC Pharmaceuticals, which can be compared to its peers in the sector. Please validate SC Pharmaceuticals information ratio, and the relationship between the downside deviation and value at risk to decide if SC Pharmaceuticals is priced adequately, providing market reflects its prevailing price of 6.02 per share. Given that SC Pharmaceuticals has jensen alpha of (0.06), we advise you to double-check SC Pharmaceuticals's latest market performance to make sure the company can sustain itself sooner or later.

SC Pharmaceuticals Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Exponential Moving Average is calculated by weighting recent values of SC Pharmaceuticals more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

SC Pharmaceuticals Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SC Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on SC Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SC Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Abraham William Tober over a month ago via Macroaxis 
Acquisition by Abraham William Tober of 16300 shares of SC Pharmaceuticals subject to Rule 16b-3
Ra Capital Management Lp over three months ago via Macroaxis 
Sale by Ra Capital Management Lp of 110588 shares of SC Pharmaceuticals
Abraham William Tober over three months ago via Macroaxis 
Acquisition by Abraham William Tober of 32600 shares of SC Pharmaceuticals subject to Rule 16b-3
Rachael Nokes over three months ago via Macroaxis 
Acquisition by Rachael Nokes of 49200 shares of ScPharmaceuticals subject to Rule 16b-3
Bonstein Sara over a year ago via Macroaxis 
Acquisition by Bonstein Sara of 12248 shares of ScPharmaceuticals subject to Rule 16b-3
Minnie BaylorHenry over a year ago via Macroaxis 
Acquisition by Minnie BaylorHenry of 6124 shares of ScPharmaceuticals subject to Rule 16b-3
5am Opportunities I Gp Llc over a year ago via Macroaxis 
ScPharmaceuticals exotic insider transaction detected
Orbimed Advisors Llc over a year ago via Macroaxis 
Purchase by Orbimed Advisors Llc of 231200 shares of ScPharmaceuticals
Ra Capital Management Lp over a year ago via Macroaxis 
Purchase by Ra Capital Management Lp of 271993 shares of ScPharmaceuticals
Ra Capital Management Lp over a year ago via Macroaxis 
Purchase by Ra Capital Management Lp of 271993 shares of ScPharmaceuticals
Rachael Nokes over a year ago via Macroaxis 
Acquisition by Rachael Nokes of 44500 shares of ScPharmaceuticals subject to Rule 16b-3
5am Partners Iv Llc over a year ago via Macroaxis 
Conversion by 5am Partners Iv Llc of 61795 shares of ScPharmaceuticals

SC Pharmaceuticals Predictive Daily Indicators

SC Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SC Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

SC Pharmaceuticals Forecast Models

SC Pharmaceuticals time-series forecasting models is one of many SC Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SC Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About SC Pharmaceuticals Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how SC Pharmaceuticals stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SC Pharmaceuticals shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as SC Pharmaceuticals. By using and applying SC Pharmaceuticals Stock analysis, traders can create a robust methodology for identifying SC Pharmaceuticals entry and exit points for their positions.
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The companys lead product candidate is FUROSCIX that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SC Pharmaceuticals to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Commodity Channel Index Now


Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module
Additionally, take a look at World Market Map. Note that the SC Pharmaceuticals information on this page should be used as a complementary analysis to other SC Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for SC Pharmaceuticals Stock analysis

When running SC Pharmaceuticals price analysis, check to measure SC Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SC Pharmaceuticals is operating at the current time. Most of SC Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of SC Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move SC Pharmaceuticals' price. Additionally, you may evaluate how the addition of SC Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
CEO Directory
Screen CEOs from public companies around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
The market value of SC Pharmaceuticals is measured differently than its book value, which is the value of SC Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of SC Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is SC Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SC Pharmaceuticals' market value can be influenced by many factors that don't directly affect SC Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SC Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine SC Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SC Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.